Oncocyte Corp CEO Ronald Andrews receives $2.1M in 2019
Oncocyte Corp reports 2019 executive compensation
By ExecPay News
Published: May 21, 2021
Oncocyte Corp reported fiscal year 2019 executive compensation information on May 21, 2021.
In 2019, six executives at Oncocyte Corp received on average a compensation package of $1.3M, a 46% increase compared to previous year.
Average pay of disclosed executives at Oncocyte Corp
Ronald Andrews, Chief Executive Officer, received $2.1M in total. 79% of Andrews' compensation, or $1.6M, was in option awards. Andrews also received $276K in salary and $163K in stock awards.
William Annett, Chief Executive Officer, received a compensation package of $1.6M, which increased by 76% compared to previous year. 59% of the compensation package, or $956K, was in option awards.
Lyndal K. Hesterberg, Chief Scientific Officer, earned $1.2M in 2019, a 43% increase compared to previous year.
Mitchell Levine, Chief Financial Officer, received $1.2M in 2019, which increases by 33% compared to 2018.
Albert P. Parker, Chief Operating Officer, earned $911K in 2019.
Padma Sundar, Senior Vice President, Marketing and Market Access, received $774K in 2019.
Related executives
Padma Sundar
Oncocyte Corp
Senior Vice President, Marketing and Market Access
Albert Parker
Oncocyte Corp
Chief Operating Officer
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
Lyndal Hesterberg
Oncocyte Corp
Chief Scientific Officer
Mitchell Levine
Oncocyte Corp
Chief Financial Officer
William Annett
Oncocyte Corp
Chief Executive Officer
You may also like
Source: SEC filing on May 21, 2021.